gnfebqsesfqi

[innomma]

hydroxychloroquine 200 mg anti-inflammatory properties have led to its exploration in the management of inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis. While initial studies show promise in reducing disease activity and improving symptoms, further research is needed to establish its long-term efficacy and safety in this context.